X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (76) 76
physics (65) 65
particle physics (63) 63
high energy physics - experiment (58) 58
fysik (48) 48
natural sciences (48) 48
naturvetenskap (48) 48
physical sciences (48) 48
nuclear experiment (42) 42
physics, particles & fields (40) 40
high energy physics (39) 39
physics - high energy physics - experiment (37) 37
physics of elementary particles and fields (37) 37
phenomenology (25) 25
collisions (24) 24
subatomic physics (24) 24
subatomär fysik (24) 24
nuclear physics (22) 22
astronomy & astrophysics (21) 21
detectors (19) 19
physics, nuclear (19) 19
elementary particles, quantum field theory (17) 17
index medicus (17) 17
quantum field theories, string theory (17) 17
female (16) 16
humans (16) 16
male (16) 16
aged (14) 14
middle aged (14) 14
model (14) 14
analysis (13) 13
astronomy, astrophysics and cosmology (13) 13
carcinoma, non-small-cell lung - drug therapy (13) 13
large hadron collider (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
chemotherapy (12) 12
lung neoplasms - drug therapy (12) 12
measurement science and instrumentation (12) 12
nuclear energy (12) 12
nuclear physics, heavy ions, hadrons (12) 12
oncology (12) 12
particle physics - experiment (12) 12
research (12) 12
care and treatment (11) 11
cern lhc coll (11) 11
hep (11) 11
lung cancer, non-small cell (11) 11
transverse momentum (11) 11
treatment outcome (11) 11
astrophysics (10) 10
decay (10) 10
experimental results (10) 10
hadrons (10) 10
lead (10) 10
luminosity (10) 10
searching (10) 10
standard model (10) 10
adult (9) 9
alice (9) 9
drug therapy (9) 9
ex (9) 9
hadron-hadron scattering (9) 9
higgs bosons (9) 9
physics and astronomy (9) 9
antibodies, monoclonal - administration & dosage (8) 8
hematology, oncology and palliative medicine (8) 8
neoplasm staging (8) 8
nucl (8) 8
nuclear theory (8) 8
particle accelerators (8) 8
particle collisions (8) 8
physics, multidisciplinary (8) 8
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (7) 7
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (7) 7
[phys.nexp]physics [physics]/nuclear experiment [nucl-ex] (7) 7
cancer (7) 7
carcinoma, non-small-cell lung - mortality (7) 7
carcinoma, non-small-cell lung - pathology (7) 7
cross sections (7) 7
disease-free survival (7) 7
engineering (7) 7
high energy astrophysical phenomena (7) 7
instrumentation and detectors (7) 7
leptons (7) 7
lhc (7) 7
lung neoplasms - mortality (7) 7
nuclear and high energy physics (7) 7
p p: scattering (7) 7
parton distributions (7) 7
performance (7) 7
protons (7) 7
root-s=7 tev (7) 7
物理学 (7) 7
114 physical sciences (6) 6
aged, 80 and over (6) 6
antineoplastic agents (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bosons (6) 6
clinical trials (6) 6
double-blind method (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (8) 8
UTL at Downsview - May be requested (8) 8
Gerstein Science - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Pontifical Inst. Mediaeval Studies - Periodical Stacks (1) 1
Regis College - Reference (1) 1
Regis College - Storage (1) 1
Robarts - Reference (1) 1
St. Augustine's Seminary - Reference (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Reference (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 255 - 265
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 143 - 155
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 33 - 42
Summary Background Findings from the phase 3 First-Line ErbituX in lung cancer (FLEX) study showed that the addition of cetuximab to first-line chemotherapy... 
Hematology, Oncology and Palliative Medicine | BREAST-CANCER | BIOMARKERS | GROWTH-FACTOR RECEPTOR | OVEREXPRESSION | ONCOLOGY | PROTEIN EXPRESSION | IN-SITU HYBRIDIZATION | CARCINOMAS | GENE AMPLIFICATION | ESTROGEN-RECEPTOR | III TRIAL | Immunohistochemistry | Lung Neoplasms - drug therapy | Up-Regulation | Prospective Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Patient Selection | Young Adult | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Time Factors | Vinblastine - analogs & derivatives | Aged, 80 and over | Biomarkers, Tumor - metabolism | Brazil | Adult | Female | Biomarkers, Tumor - antagonists & inhibitors | Cetuximab | Odds Ratio | Republic of Korea | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - enzymology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Care and treatment | Patient outcomes | Oncology, Experimental | Research | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Cancer patients | Chemotherapy | Product development | Tumors | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1525 - 1531
Summary Background Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in... 
Internal Medicine | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | THERAPY | CISPLATIN | COMBINATION | GEMCITABINE | ERLOTINIB | PACLITAXEL | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptor, Epidermal Growth Factor - drug effects | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Young Adult | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Proportional Hazards Models | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Research | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Cancer | Drugs | Studies | Data analysis | Lung cancer | Acne | Monoclonal antibodies | Clinical medicine | Kinases | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 328 - 337
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 8, pp. 795 - 805
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. 1369 - 1378
Journal Article
by Aad, G and Abajyan, T and Abbott, B and Abdallah, J and Abdel Khalek, S and Abdelalim, A.A and Abdinov, O and Aben, R and Abi, B and Abolins, M and AbouZeid, O.S and Abramowicz, H and Abreu, H and Acharya, B.S and Adamczyk, L and Adams, D.L and Addy, T.N and Adelman, J and Adomeit, S and Adragna, P and Adye, T and Aefsky, S and Aguilar-Saavedra, J.A and Agustoni, M and Aharrouche, M and Ahlen, S.P and Ahles, F and Ahmad, A and Ahsan, M and Aielli, G and Akdogan, T and Åkesson, T.P.A and Akimoto, G and Akimov, A.V and Alam, M.A and Alam, M.S and Albert, J and Albrand, S and Aleksa, M and Aleksandrov, I.N and Alessandria, F and Alexa, C and Alexander, G and Alexandre, G and Alexopoulos, T and Alhroob, M and Aliev, M and Alimonti, G and Alison, J and Allbrooke, B.M.M and Allport, P.P and Allwood-Spiers, S.E and Almond, J and Aloisio, A and Alon, R and Alonso, F and Alonso, A and Altheimer, A and Alvarez Gonzalez, B and Alviggi, M.G and Amako, K and Amelung, C and Ammosov, V.V and Amor Dos Santos, S.P and Amorim, A and Amram, N and Anastopoulos, C and Ancu, L.S and Andari, N and Andeen, T and Anders, C.F and Anders, G and Anderson, K.J and Andreazza, A and Andrei, V and Andrieux, M.-L and Anduaga, X.S and Angelidakis, S and Anger, P and Angerami, A and Anghinolfi, F and Anisenkov, A and Anjos, N and Annovi, A and Antonaki, A and Antonelli, M and Antonov, A and Antos, J and Anulli, F and Aoki, M and Aoun, S and Aperio Bella, L and Apolle, R and Arabidze, G and Aracena, I and Arai, Y and Arce, A.T.H and Arfaoui, S and Arguin, J.-F and Arik, M and ... and ATLAS Collaboration and BROOKHAVEN NATIONAL LABORATORY (BNL) and Partikel- och astropartikelfysik and Skolan för teknikvetenskap (SCI) and KTH and Fysik
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 1 - 29
Journal Article